BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FDA, National Institutes of Health (NIH) and Genzyme Corporation (GENZ) Reveal Their Strategies to Overcome Viral Contamination at the Pathogen Safety Summit


9/6/2012 10:29:16 AM

LONDON, September 6, 2012 /PRNewswire/ --

Leading biotech and biopharma organisations are coming together to learn how to maximise their viral security strategies and the new technologies available from the FDA, NIBSC, NIH and a range of industry experts including Genzyme, Baxter and Amgen at the Pathogen Safety Summit this November.

Pharma IQ's Pathogen Safety Summit is back for its third year to offer the opportunity to learn and hear insights from key regulatory bodies, industry representatives and experts in viral safety on the current viral security strategies and technologies.

As the cost of contamination is huge, both financially and to an organisation's reputation, this event will cover:

  • The latest regulatory updates on viral safety from Arifa Khan, FDA and Dr Wahiba Oualikene-Gonin, AFSAAPS
  • James Gilbert, Biogen Idec and Lada Laenen, Genzyme, will share best practices for the successful evaluation of raw materials
  • Knowledge of the most prevalent pathogens currently being found in biologics from Phil Minor, NIBSC
  • Adam Polermo, Genzyme, present the latest data on the implementation of deep sequencing technologies
  • Rebecca Sheets, NIH, streamlines the viral screening process and rationalise the implementation of the latest technologies

This interactive, senior-level summit will allow organisations to benchmark themselves against the leading experts in biosafety.

Find the full program, event details and registration information at http://www.pathogensafetysummit.com/news, call +44(0)20-7036-1300 or email enquire@iqpc.co.uk.

Media contact: Nishkala Thiru, +44(0)20-7368-9725, Nishkala.Thiru@iqpc.co.uk or visit http://www.pathogensafetysummit.com/news.

Press are invited to attend this important industry forum, if you would like a complimentary press pass please email Nishkala Thiru at Nishkala.Thiru@iqpc.co.uk


SOURCE Pharma IQ



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES